TSPO and Schnyder corneal dystrophy: Treatment of SCD mice with TSPO-selective drug ligand N,N-dihexyl-2-(4-fluorophenyl) indole-3-acetamide (FGIN-1-27) produces eugonadal levels of testosterone.